New study targets diabetes disparities in black patients
NCT ID NCT07325435
First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study looks at how two types of diabetes medicines (GLP-1 receptor agonists and SGLT-2 inhibitors) affect insulin production in Black patients with type 2 diabetes. About 60 Black adults with recent-onset diabetes will take one of the drugs for 16 weeks. The goal is to see which drug better helps the pancreas make insulin, since Black patients may have a unique ability to recover this function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
SUNY Downstate Health Sciences University
Brooklyn, New York, 11203, United States
Conditions
Explore the condition pages connected to this study.